Anti-Non-Radioactive Nucleic Acid Labeling Antibodies

Promoting nucleic acid POCT product development

NALFIA is a general device that combines lateral flow technology and the immunoassay principle for the detection of nucleic acid-related products, such as PCR products and genetic amplicons. As shown in Figure 1, the NALFIA device is designed for the indirect detection of amplified PCR products using antibodies against primer-tags, FITC, DIG and biotin. Each monoclonal antibody can specifically recognize the corresponding tag. Creative Diagnostics provides a series of antibodies against nucleic acid tags that are widely used in NALFIA. These antibodies can specifically bind to FITC, digoxigenin, biotin and FAM, facilitating the development of NALF methods. 

Fig. 1 Schematic illustration of NALF design.(Kamphee H.; et al. PLoS One. 2015) 

Key Features:

 ● Good sensitivity and specificity

 ● Suitable for NALFIA (Nucleic Acid Lateral Flow Immunoassay) development

 ● Wide range of antibody products

Related Materials

(주)엘바이오시스템은 Creative Diagnostics의 한국공식대리점입니다.

제품의 주문 및 관련정보가 필요하시면 전화, 이메일로 문의해 주세요.